“Cloning research ‘clearly upsets the general public’ yet it has limited potential for treating disease and adds little to scientific understanding of human biology, according to Professor Austin Smith of the University of Cambridge...’Its prominence is out of proportion to the significance of what’s being done, and there are real question marks about whether it has any utility at all.”
Gee, really? I guess that is why this article in the London Times will never be published in the New York Times.
Time is short, so I’ll be direct: FIRST THINGS needs you. And we need you by December 31 at 11:59 p.m., when the clock will strike zero. Give now at supportfirstthings.com.
First Things does not hesitate to call out what is bad. Today, there is much to call out. Yet our editors, authors, and readers like you share a greater purpose. And we are guided by a deeper, more enduring hope.
Your gift of $50, $100, or even $250 or more will bring this message of hope to many more people in the new year.
Make your gift now at supportfirstthings.com.
First Things needs you. I’m confident you’ll answer the call.
